[Development of an OCTA-based risk prediction model for retinopathy in patients with obstructive sleep apnea and hypertension].
Abstract
The XGBoost-based multimodal model integrating OCTA and PSG biomarkers enables precise risk stratification for retinopathy in OSA-hypertension comorbidity. This non-invasive framework elucidates the synergistic interplay between microvascular dysfunction and nocturnal hypoxemia, providing a quantifiable tool for early risk prediction of target organ damage. Its clinical translation potential lies in guiding personalized interventions to mitigate systemic complications in high-risk populations.
Publication details
- Journal / source
- PubMed
- Volume
- 40
- Issue
- 1
- Pages
- 28–33
- Publication date
- 1 January 2026
- Language
- ZH